For field providers, the goal isn’t just faster paperwork — it’s smarter, safer documentation that puts patient care first. The post Reducing EMS Documentation Time Without Sacrificing Accuracy appeared first on MedCity News.
Could healthcare organizations be doing more to open their digital front door? According to a 2024 study by HIMSS researchers, hospitals that embrace digital technology see stronger patient experience outcomes. This aligns with Experian Health’s most recent State of Patient Access (SOPA) survey, in which patients and providers agreed that patient access had improved thanks…
Ascension is pushing AI beyond note-taking to tackle the billing, order entry and nursing handoff work still weighing on clinicians after a patient visit ends. The post How to Keep Clinicians Satisfied, the Ascension Way appeared first on MedCity News.
Verily has launched a free consumer health app that aggregates users’ medical records, helps them track their habits and delivers personalized preventive care recommendations. The app also features an AI-powered health assistant that contextualizes users’ data. The post Verily Launches Free Consumer Health App to Put AI-Powered Insights in Users’ Hands appeared first on MedCity…
Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics. The post Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect appeared first on MedCity News.
[Sponsored] In an interview, Abarca Chief Information Officer Serge Perras discussed how Abarca is implementing AI and where he sees the most value for PBMs. The post AI Is at the Heart of PBM Evolution appeared first on MedCity News.
The success of Pluvicto has created a new challenge in prostate cancer, one the field has not yet fully named or defined. The post What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking Shape appeared first on MedCity News.
Applications of SandboxAQ’s large quantitative models (LQMs) technology include running simulations that identify new biomarkers and optimize clinical development of drug candidates. The company spun out of Alphabet in 2022. The post AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More appeared first on MedCity News.
Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to “buy low and sell high” by purchasing discounted medications and charging insured patients full price. The post Why Employers Think the 340B Program Needs Reform appeared first on MedCity News.
Merck KGaA’s pimicotinib led to statistically significant improvement on multiple measures of its Phase 3 test in tenosynovial giant cell tumor, positioning the drug to potentially compete with medications from Daiichi Sankyo and Ono Pharma. The Phase 3 results were presented during the annual meeting of the American Society of Clinical Oncology. The post At…